Nervous System and Mental Disorders
Conditions
Interventions
oliceridine group:receive oliceridine
Sufentanil group:receive Sufentanil
Sponsors
Ningbo NO.2 Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1. Scheduled for hysteroscopic day surgery. 2. Anesthesia method: general anesthesia via laryngeal mask. 3. Use of anesthetic analgesics during surgery (Sufentanil or Oxaylide). 4. Age between 18 and 65 years. 5. BMI between 18 and 28 kg/m². 6. ASA classification I-II. 7. Voluntarily participate in the study and sign the informed consent form.
Exclusion criteria
Exclusion criteria: 1. Refusal to participate in the study. 2. Presence of neuropsychiatric disorders or language impairment. 3. Recent use of anticholinergics, anxiolytics, antidepressants, or anticonvulsants. 4. History of organic brain disease or cerebrovascular disease. 5. History of severe liver or kidney dysfunction. 6. Long-term oral opioid analgesic use for 3 months or more. 7. Illiteracy. 8. Allergy to drugs used in the study. 9. History of addiction, drug dependence, or alcohol/drug abuse. 10. Participation in another clinical trial within the last 4 weeks.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| the DSST score 30 minutes after anesthesia recovery ;the TMT-A score 30 minutes after anesthesia recovery ;the TMT-B score 30 minutes after anesthesia recovery ;Postoperative fatigue score; | — |
Secondary
| Measure | Time frame |
|---|---|
| Postoperative adverse reactions;Postoperative pain score;Postoperative recovery quality; | — |
Countries
China
Contacts
Public ContactAn Xiujun
Ningbo NO.2 Hospital
Outcome results
None listed